Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1.

Aurora Biosynthetics, a pioneering RNA therapeutics manufacturer company, announced its official launch, ushering in a new ...

Novo Nordisk's deal with Korro is worth a total of $530 million in research and development (R&D) funding, milestone payments, royalties, and up-front payments to get the ball rolling. That makes the ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

Modified nucleotides like m5C in saRNA enhance vaccine efficacy, stability, and reduce inflammation, offering a promising ...

Cartesian Therapeutics has a strong cash position after a $130 million equity raise, extending its runway to support upcoming ...

The Francis College of Engineering, Department of Chemical Engineering, invites you to attend a Doctoral Dissertation defense by Richard Marx on: Rethinking Classical Cellulose Oligo (dT) mRNA ...

In the past 60 days, the Zacks Consensus Estimate for Arcturus’ 2024 loss per share has narrowed from $4.39 to $2.60. Also, the Zacks Consensus Estimate for 2025 has moved from a loss of 45 cents to ...

Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system — even between ...